Abstract
We studied the telithromycin, erythromycin, azithromycin, and clindamycin susceptibilities of serotype III macrolide-resistant group B streptococci, together with genetic mechanisms of resistance and genomic diversity. ermB, ermA, and mefA were found in, respectively, 57, 32, and 9% of isolates. The telithromycin MIC at which 90% of isolates were inhibited was 0.5 micro g/ml. Macrolide resistance was associated with dissemination of resistance determinants among isolates of different genetic backgrounds.
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Bacterial Proteins / genetics
-
Drug Resistance, Bacterial
-
Erythromycin / pharmacology
-
Female
-
Genes, Bacterial / genetics
-
Humans
-
Infant, Newborn
-
Ketolides*
-
Macrolides / pharmacology*
-
Membrane Proteins / genetics
-
Methyltransferases / genetics
-
Microbial Sensitivity Tests
-
Pregnancy
-
Reverse Transcriptase Polymerase Chain Reaction
-
Streptococcal Infections / microbiology*
-
Streptococcus agalactiae / drug effects*
-
Streptococcus agalactiae / genetics*
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Ketolides
-
Macrolides
-
MefA protein, Streptococcus
-
Membrane Proteins
-
Erythromycin
-
Methyltransferases
-
ErmA protein, Bacteria
-
rRNA (adenosine-O-2'-)methyltransferase
-
telithromycin